{"pmid":32298769,"title":"COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care.","text":["COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care.","The coronavirus disease 2019 (COVID-19) pandemic has shattered the meticulously developed processes by which we delivered quality care for patients with cirrhosis. Care has been transformed by the crisis, but enduring lessons have been learned. In this article, we review how COVID-19 will impact cirrhosis care. We describe how this impact unfolds over 3 waves; i) an intense period with prioritized high-acuity care with delayed elective procedures and routine care during physical distancing, ii) a challenging 'return to normal' following the end of physical distancing, with increased emergent decompensations, morbidity, and systems of care overwhelmed by the backlog of deferred care, and iii) a protracted period of suboptimal outcomes characterized by missed diagnoses, progressive disease and loss to follow-up. We outline the concrete steps required to preserve the quality of care provided to patients with cirrhosis. This includes an intensification of the preventative care provided to patients with compensated cirrhosis, proactive chronic disease management, robust telehealth programs, and a reorganization of care delivery to provide a full service of care with flexible clinical staffing. Managing the pandemic of a serious chronic disease in the midst of a global infectious pandemic is challenging. It is incumbent upon the entire healthcare establishment to be strong enough to weather the storm. Change is needed.","J Hepatol","Tapper, Elliot B","Asrani, Sumeet K","32298769"],"abstract":["The coronavirus disease 2019 (COVID-19) pandemic has shattered the meticulously developed processes by which we delivered quality care for patients with cirrhosis. Care has been transformed by the crisis, but enduring lessons have been learned. In this article, we review how COVID-19 will impact cirrhosis care. We describe how this impact unfolds over 3 waves; i) an intense period with prioritized high-acuity care with delayed elective procedures and routine care during physical distancing, ii) a challenging 'return to normal' following the end of physical distancing, with increased emergent decompensations, morbidity, and systems of care overwhelmed by the backlog of deferred care, and iii) a protracted period of suboptimal outcomes characterized by missed diagnoses, progressive disease and loss to follow-up. We outline the concrete steps required to preserve the quality of care provided to patients with cirrhosis. This includes an intensification of the preventative care provided to patients with compensated cirrhosis, proactive chronic disease management, robust telehealth programs, and a reorganization of care delivery to provide a full service of care with flexible clinical staffing. Managing the pandemic of a serious chronic disease in the midst of a global infectious pandemic is challenging. It is incumbent upon the entire healthcare establishment to be strong enough to weather the storm. Change is needed."],"journal":"J Hepatol","authors":["Tapper, Elliot B","Asrani, Sumeet K"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32298769","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jhep.2020.04.005","keywords":["Hepatic encephalopathy","Hepatocellular carcinoma","Liver disease","Telemedicine","Varices"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664266651255701504,"score":8.233237,"similar":[{"pmid":32275784,"title":"Telemedicine in Liver Disease and Beyond: Can the COVID-19 Crisis Lead to Action?","text":["Telemedicine in Liver Disease and Beyond: Can the COVID-19 Crisis Lead to Action?","Evidence strongly supports that access to specialty gastroenterology or hepatology care in cirrhosis is associated with higher adherence to guideline-recommended care and improves clinical outcomes. Presently, only about one half of acute care hospitalizations for cirrhosis-related complications result in inpatient specialty care and the current hepatology workforce cannot meet the demand of patients with liver disease nationwide, particularly in less densely populated areas and in community-based practices not affiliated with academic centers. Telemedicine, defined as the delivery of health care services at a distance using electronic means for diagnosis and treatment, holds tremendous promise to increase access to broadly specialty care. The technology is cheap and easy to use, however, is presently limited in scale by interstate licensing restrictions and reimbursement barriers. The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) has, in the short-term, accelerated the growth of telemedicine delivery as a public health and social distancing measure. Herein, we examine whether this public health crisis can accelerate the national conversation about broader adoption of telemedicine for routine medical care in non-crisis situations using a case series from our telehepatology program as a pragmatic example.","Hepatology","Serper, Marina","Cubell, Allen W","Deleener, Mary Elisabeth","Casher, Tara K","Rosenberg, Dale J","Whitebloom, Dale","Rosin, Roy M","32275784"],"abstract":["Evidence strongly supports that access to specialty gastroenterology or hepatology care in cirrhosis is associated with higher adherence to guideline-recommended care and improves clinical outcomes. Presently, only about one half of acute care hospitalizations for cirrhosis-related complications result in inpatient specialty care and the current hepatology workforce cannot meet the demand of patients with liver disease nationwide, particularly in less densely populated areas and in community-based practices not affiliated with academic centers. Telemedicine, defined as the delivery of health care services at a distance using electronic means for diagnosis and treatment, holds tremendous promise to increase access to broadly specialty care. The technology is cheap and easy to use, however, is presently limited in scale by interstate licensing restrictions and reimbursement barriers. The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) has, in the short-term, accelerated the growth of telemedicine delivery as a public health and social distancing measure. Herein, we examine whether this public health crisis can accelerate the national conversation about broader adoption of telemedicine for routine medical care in non-crisis situations using a case series from our telehepatology program as a pragmatic example."],"journal":"Hepatology","authors":["Serper, Marina","Cubell, Allen W","Deleener, Mary Elisabeth","Casher, Tara K","Rosenberg, Dale J","Whitebloom, Dale","Rosin, Roy M"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32275784","week":"202015|Apr 06 - Apr 12","doi":"10.1002/hep.31276","keywords":["connected health","hepatology","mHealth","telehealth","telehepatology"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663712077912473601,"score":369.13724},{"pmid":32304401,"title":"Orthopaedic Surgical Selection and Inpatient Paradigms During the Coronavirus COVID-19 Pandemic.","text":["Orthopaedic Surgical Selection and Inpatient Paradigms During the Coronavirus COVID-19 Pandemic.","The Novel Coronavirus (COVID-19) pandemic, also known as SARS-CoV-2, has placed an immense strain on health care systems across the entire world. Consequently, multiple federal and state governments have placed restrictions on hospitals such as limiting \"elective surgery\" and recommending social or physical distancing. We review the literature on several areas that have been affected including surgical selection, inpatient care, and physician well-being. These areas affecting inpatient paradigms include surgical priority, physical or social distancing, file sharing for online clinical communications, and physician wellness. During this crisis, it is important that orthopaedic departments place an emphasis on personnel safety and slowing the spread of the virus, so that the department can still maintain vital functions. Physical Distancing and emerging technologies such as inpatient telemedicine and online file sharing applications can enable orthopaedic programs to still function, while attempting to protect medical staff and patients from COVID-19 spread. This literature review sought to provide evidence-based guidance to orthopaedic departments during an unprecedented time. Orthopaedic surgeons should follow the Centers for Disease Control and Prevention (CDC) guidelines, wear PPE when appropriate, have teams created utilizing physical distancing, understand the department's policy on elective surgery, and engage in routines which enhance physician wellness.","J Am Acad Orthop Surg","Massey, Patrick A","McClary, Kaylan","Zhang, Andrew S","Savoie, Felix H","Barton, R Shane","32304401"],"abstract":["The Novel Coronavirus (COVID-19) pandemic, also known as SARS-CoV-2, has placed an immense strain on health care systems across the entire world. Consequently, multiple federal and state governments have placed restrictions on hospitals such as limiting \"elective surgery\" and recommending social or physical distancing. We review the literature on several areas that have been affected including surgical selection, inpatient care, and physician well-being. These areas affecting inpatient paradigms include surgical priority, physical or social distancing, file sharing for online clinical communications, and physician wellness. During this crisis, it is important that orthopaedic departments place an emphasis on personnel safety and slowing the spread of the virus, so that the department can still maintain vital functions. Physical Distancing and emerging technologies such as inpatient telemedicine and online file sharing applications can enable orthopaedic programs to still function, while attempting to protect medical staff and patients from COVID-19 spread. This literature review sought to provide evidence-based guidance to orthopaedic departments during an unprecedented time. Orthopaedic surgeons should follow the Centers for Disease Control and Prevention (CDC) guidelines, wear PPE when appropriate, have teams created utilizing physical distancing, understand the department's policy on elective surgery, and engage in routines which enhance physician wellness."],"journal":"J Am Acad Orthop Surg","authors":["Massey, Patrick A","McClary, Kaylan","Zhang, Andrew S","Savoie, Felix H","Barton, R Shane"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32304401","week":"202016|Apr 13 - Apr 19","doi":"10.5435/JAAOS-D-20-00360","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664431720485617664,"score":286.44244},{"pmid":32174095,"title":"[Advances in the research of mechanism of pulmonary fibrosis induced by Corona Virus Disease 2019 and the corresponding therapeutic measures].","text":["[Advances in the research of mechanism of pulmonary fibrosis induced by Corona Virus Disease 2019 and the corresponding therapeutic measures].","The Corona Virus Disease 2019 (COVID-19) outbroke in Wuhan, China in December 2019 and the severe acute respiratory syndrome (SARS) outbroke in Guangzhou, China in 2003 were caused by highly pathogenic coronaviruses with high homology. Since the 2019 novel coronavirus has strong transmissibility and progress rapidly. It has caused negative social effects and massive economic damage on a global scale. While there is currently no vaccine or effective drugs. Pulmonary fibrosis is a pulmonary disease with progressive fibrosis, which is the main factor leading to pulmonary dysfunction and quality of life decline in SARS survivors after recovery. Extensive epidemiological, viral immunological, and current clinical evidences support the possibility that pulmonary fibrosis may be one of the major complications in COVID-19 patients. Although there are no reports on the mechanism of COVID-19 inducing pulmonary fibrosis, based on the existing theoretical basis, we focus on the possible mechanism of COVID-19 sustained lung damaging, the key role of abnormal immune mechanism in the initiation and promotion of pulmonary fibrosis, and the corresponding therapeutic measures.","Zhonghua Shao Shang Za Zhi","Wang, J","Wang, B J","Yang, J C","Wang, M Y","Chen, C","Luo, G X","He, W F","32174095"],"abstract":["The Corona Virus Disease 2019 (COVID-19) outbroke in Wuhan, China in December 2019 and the severe acute respiratory syndrome (SARS) outbroke in Guangzhou, China in 2003 were caused by highly pathogenic coronaviruses with high homology. Since the 2019 novel coronavirus has strong transmissibility and progress rapidly. It has caused negative social effects and massive economic damage on a global scale. While there is currently no vaccine or effective drugs. Pulmonary fibrosis is a pulmonary disease with progressive fibrosis, which is the main factor leading to pulmonary dysfunction and quality of life decline in SARS survivors after recovery. Extensive epidemiological, viral immunological, and current clinical evidences support the possibility that pulmonary fibrosis may be one of the major complications in COVID-19 patients. Although there are no reports on the mechanism of COVID-19 inducing pulmonary fibrosis, based on the existing theoretical basis, we focus on the possible mechanism of COVID-19 sustained lung damaging, the key role of abnormal immune mechanism in the initiation and promotion of pulmonary fibrosis, and the corresponding therapeutic measures."],"journal":"Zhonghua Shao Shang Za Zhi","authors":["Wang, J","Wang, B J","Yang, J C","Wang, M Y","Chen, C","Luo, G X","He, W F"],"date":"2020-03-17T11:00:00Z","year":2020,"_id":"32174095","week":"202012|Mar 16 - Mar 22","doi":"10.3760/cma.j.cn501120-20200307-00132","keywords":["Acute respiratory distress syndrome","Corona Virus Disease 2019","Cytokines","Immune system","Pulmonary fibrosis"],"source":"PubMed","locations":["Guangzhou","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1663352133905285120,"score":276.0936},{"pmid":32251003,"title":"Lung transplantation as therapeutic option in acute respiratory distress syndrome for COVID-19-related pulmonary fibrosis.","text":["Lung transplantation as therapeutic option in acute respiratory distress syndrome for COVID-19-related pulmonary fibrosis.","BACKGROUND: Critical patients with the 2019 coronavirus disease (COVID-19), even those whose nucleic acid test results had turned negative and those receiving maximal medical support, have been noted to progress to irreversible fatal respiratory failure. Lung transplantation (LT) as the sole therapy for end-stage pulmonary fibrosis related to acute respiratory distress syndrome has been considered as the ultimate rescue therapy for these patients. METHODS: From February 10 to March 10, 2020, three male patients were urgently assessed and listed for transplantation. After conducting a full ethical review and after obtaining assent from the family of the patients, we performed three LT procedures for COVID-19 patients with illness durations of >1 month and extremely high sequential organ failure assessment (SOFA) scores. RESULTS: Two of the three recipients survived post-LT and started participating in a rehabilitation program. Pearls of the LT team collaboration and perioperative logistics were summarized and continually improved. The pathological results of the explanted lungs were concordant with the critical clinical manifestation, and provided insight towards better understanding of the disease. Government health affair systems, virology detection tools, and modern communication technology all play key roles towards the survival of the patients and their rehabilitation. CONCLUSIONS: Lung transplantation can be performed in end-stage patients with respiratory failure due to COVID-19-related pulmonary fibrosis. If confirmed positive-turned-negative virology status without organ dysfunction, LT provided the final option for these patients to avoid certain death, with proper protection of transplant surgeons and medical staffs. By ensuring instant seamless care for both patients and medical teams, the goal of reducing the mortality rate and salvaging the lives of patients with COVID-19 can be attained.","Chin Med J (Engl)","Chen, Jing-Yu","Qiao, Kun","Liu, Feng","Wu, Bo","Xu, Xin","Jiao, Guo-Qing","Lu, Rong-Guo","Li, Hui-Xing","Zhao, Jin","Huang, Jian","Yang, Yi","Lu, Xiao-Jie","Li, Jia-Shu","Jiang, Shu-Yun","Wang, Da-Peng","Hu, Chun-Xiao","Wang, Gui-Long","Huang, Dong-Xiao","Jiao, Guo-Hui","Wei, Dong","Ye, Shu-Gao","Huang, Jian-An","Zhou, Li","Zhang, Xiao-Qin","He, Jian-Xing","32251003"],"abstract":["BACKGROUND: Critical patients with the 2019 coronavirus disease (COVID-19), even those whose nucleic acid test results had turned negative and those receiving maximal medical support, have been noted to progress to irreversible fatal respiratory failure. Lung transplantation (LT) as the sole therapy for end-stage pulmonary fibrosis related to acute respiratory distress syndrome has been considered as the ultimate rescue therapy for these patients. METHODS: From February 10 to March 10, 2020, three male patients were urgently assessed and listed for transplantation. After conducting a full ethical review and after obtaining assent from the family of the patients, we performed three LT procedures for COVID-19 patients with illness durations of >1 month and extremely high sequential organ failure assessment (SOFA) scores. RESULTS: Two of the three recipients survived post-LT and started participating in a rehabilitation program. Pearls of the LT team collaboration and perioperative logistics were summarized and continually improved. The pathological results of the explanted lungs were concordant with the critical clinical manifestation, and provided insight towards better understanding of the disease. Government health affair systems, virology detection tools, and modern communication technology all play key roles towards the survival of the patients and their rehabilitation. CONCLUSIONS: Lung transplantation can be performed in end-stage patients with respiratory failure due to COVID-19-related pulmonary fibrosis. If confirmed positive-turned-negative virology status without organ dysfunction, LT provided the final option for these patients to avoid certain death, with proper protection of transplant surgeons and medical staffs. By ensuring instant seamless care for both patients and medical teams, the goal of reducing the mortality rate and salvaging the lives of patients with COVID-19 can be attained."],"journal":"Chin Med J (Engl)","authors":["Chen, Jing-Yu","Qiao, Kun","Liu, Feng","Wu, Bo","Xu, Xin","Jiao, Guo-Qing","Lu, Rong-Guo","Li, Hui-Xing","Zhao, Jin","Huang, Jian","Yang, Yi","Lu, Xiao-Jie","Li, Jia-Shu","Jiang, Shu-Yun","Wang, Da-Peng","Hu, Chun-Xiao","Wang, Gui-Long","Huang, Dong-Xiao","Jiao, Guo-Hui","Wei, Dong","Ye, Shu-Gao","Huang, Jian-An","Zhou, Li","Zhang, Xiao-Qin","He, Jian-Xing"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32251003","week":"202015|Apr 06 - Apr 12","doi":"10.1097/CM9.0000000000000839","source":"PubMed","topics":["Treatment","Prevention"],"weight":1,"_version_":1663352136275066882,"score":269.50003},{"pmid":32291208,"title":"Clinical and surgical consequences of the COVID-19 pandemic for patients with pediatric urological problems: Statement of the EAU guidelines panel for paediatric urology, March 30 2020.","text":["Clinical and surgical consequences of the COVID-19 pandemic for patients with pediatric urological problems: Statement of the EAU guidelines panel for paediatric urology, March 30 2020.","The COVID-19-pandemic forces hospitals to reorganize into a dual patient flow system. Healthcare professionals are forced to make decisions in patient prioritization throughout specialties. Most pediatric urology pathologies do not require immediate or urgent care, however, delay may compromise future renal function or fertility. Contact with patients and parents, either physical in safe conditions or by (video)telephone must continue. The Paediatric-Urology-Guidelines-panel of the EAU proposes recommendations on prioritization of care. Pediatric-Urology program directors must ensure education, safety and attention for mental health of staff. Upon resumption of care, adequate prioritization must ensure minimal impact on outcome.","J Pediatr Urol","Quaedackers, Josine S L T","Stein, Raimund","Bhatt, Nikita","Dogan, Hasan Serkan","Hoen, Lisette","Nijman, Rien J M","Radmayr, Christian","Silay, Mesrur Selcuk","Tekgul, Serdar","Bogaert, Guy","32291208"],"abstract":["The COVID-19-pandemic forces hospitals to reorganize into a dual patient flow system. Healthcare professionals are forced to make decisions in patient prioritization throughout specialties. Most pediatric urology pathologies do not require immediate or urgent care, however, delay may compromise future renal function or fertility. Contact with patients and parents, either physical in safe conditions or by (video)telephone must continue. The Paediatric-Urology-Guidelines-panel of the EAU proposes recommendations on prioritization of care. Pediatric-Urology program directors must ensure education, safety and attention for mental health of staff. Upon resumption of care, adequate prioritization must ensure minimal impact on outcome."],"journal":"J Pediatr Urol","authors":["Quaedackers, Josine S L T","Stein, Raimund","Bhatt, Nikita","Dogan, Hasan Serkan","Hoen, Lisette","Nijman, Rien J M","Radmayr, Christian","Silay, Mesrur Selcuk","Tekgul, Serdar","Bogaert, Guy"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32291208","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jpurol.2020.04.007","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664266295852400640,"score":267.89972}]}